4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-051305
Director sold 4,198 shares at $3.16 ($13,266)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curet Myriam Director | 2022-09-23 | Sale | −4,198 | $3.16 | $13,266 | 31,777 | D: show line 1 in the form |
| Open-market sales · 4,198 sh · avg $3.16 · $13,266 | |||||||
Loading xslF345X03/doc4.xml…